Gelonghui on October 29th ǀ Beijing Bohui Innovation Biotechnology Group (300318.SZ) released the third quarter report for 2024, with the company achieving a revenue of 0.646 billion yuan in the first three quarters, a 19.85% year-on-year decrease; a net income attributable to shareholders of the listed company of 23.7177 million yuan, a 67.77% year-on-year increase; a net income attributable to shareholders of the listed company excluding non-recurring gains and losses of 15.6564 million yuan, a 29.24% year-on-year increase; and an earnings per share of 0.0290 yuan.
博晖创新(300318.SZ)：前三季度净利润2371.77万元 同比增长67.77%
Beijing Bohui Innovation Biotechnology Group (300318.SZ): The net income in the first three quarters was 23.7177 million yuan, a year-on-year increase of 67.77%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated